Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8408 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8408 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8345 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8345 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD37 |
Approved |
0.8187 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8069 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8014 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7823 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7738 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7708 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.76 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7533 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7457 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7439 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7431 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7285 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7262 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7193 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7095 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7081 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5763 |
Approved |
0.6994 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6986 |
Remote Similarity |
NPD6671 |
Approved |
0.6982 |
Remote Similarity |
NPD7819 |
Suspended |
0.6982 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6961 |
Remote Similarity |
NPD4663 |
Approved |
0.6959 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6954 |
Remote Similarity |
NPD2970 |
Approved |
0.6954 |
Remote Similarity |
NPD2969 |
Approved |
0.6951 |
Remote Similarity |
NPD1511 |
Approved |
0.6946 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6941 |
Remote Similarity |
NPD5402 |
Approved |
0.6941 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD6099 |
Approved |
0.6937 |
Remote Similarity |
NPD6100 |
Approved |
0.6937 |
Remote Similarity |
NPD3454 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6841 |
Approved |
0.6923 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6842 |
Approved |
0.6918 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6909 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD4678 |
Approved |
0.6905 |
Remote Similarity |
NPD4675 |
Approved |
0.6899 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6897 |
Remote Similarity |
NPD3051 |
Approved |
0.6894 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD2977 |
Approved |
0.6882 |
Remote Similarity |
NPD2978 |
Approved |
0.6875 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD7466 |
Approved |
0.6871 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6867 |
Remote Similarity |
NPD1512 |
Approved |
0.6852 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD2563 |
Approved |
0.6842 |
Remote Similarity |
NPD2560 |
Approved |
0.6839 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6839 |
Remote Similarity |
NPD1247 |
Approved |
0.6839 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6835 |
Remote Similarity |
NPD4140 |
Approved |
0.6831 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6818 |
Remote Similarity |
NPD27 |
Approved |
0.6818 |
Remote Similarity |
NPD2489 |
Approved |
0.681 |
Remote Similarity |
NPD4237 |
Approved |
0.681 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6807 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6805 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.68 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6796 |
Remote Similarity |
NPD8313 |
Approved |
0.6796 |
Remote Similarity |
NPD4577 |
Approved |
0.6796 |
Remote Similarity |
NPD4578 |
Approved |
0.6796 |
Remote Similarity |
NPD8312 |
Approved |
0.679 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.679 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD5929 |
Approved |
0.6778 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6776 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6772 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.677 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6768 |
Remote Similarity |
NPD3750 |
Approved |
0.6766 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7411 |
Suspended |
0.6757 |
Remote Similarity |
NPD7157 |
Approved |
0.6746 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD7906 |
Approved |
0.6736 |
Remote Similarity |
NPD2684 |
Approved |
0.673 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6728 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6727 |
Remote Similarity |
NPD2677 |
Approved |
0.6724 |
Remote Similarity |
NPD919 |
Approved |
0.672 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6713 |
Remote Similarity |
NPD968 |
Approved |
0.6712 |
Remote Similarity |
NPD228 |
Approved |
0.6711 |
Remote Similarity |
NPD7340 |
Approved |
0.6711 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6709 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6709
|
Remote Similarity |
NPD6798 |
Discontinued |